Monoclonal antibodies for dyslipidemia in adults: a focus on vulnerable patients groups
{{output}}
Introduction: Dyslipidemia significantly contributes to atherosclerotic cardiovascular disease (ASCVD). Patients with lipid-rich vulnerable plaques are particularly susceptible to cardiovascular complications. Despite available l... ...
